Want to join the conversation?
$IFF 2Q15 PR: Reported net sales of $767.54MM vs. $788.41MM in 2Q14. Net income was $105.37MM or $1.29 per diluted share vs. $110.29MM or $1.35 per diluted share in 2Q14. Currency neutral sales improved 4% on an organic basis or 5% including the acquisition of Ottens Flavors.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?